MarketInOut Stock Screener Log In | Sign Up

Zydus Lifesciences Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 11:08
Zydus Lifesciences Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization1,125,035 mln
Float241 mln
Earnings Date11/04/2026

EPS

44.87
Exceptional

P / E

26.16
Elevated

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.15
Caution advised

1-Year Forecast

1,220.98
Fairly priced

Relative Strength

90 / 100
Top performer

Business Description

Zydus Lifesciences Limited is an India-based pharmaceutical company founded in 1952 and headquartered in Ahmedabad, operating across domestic and international markets including the United States. The company develops, manufactures, and sells a broad range of healthcare products, from generic medicines and vaccines to biosimilars and consumer health brands such as Complan, Glucon-D, and SugarFree. It also conducts research into treatments for conditions including cancer, autoimmune disorders, and metabolic diseases, while maintaining a separate business in animal health. Formerly known as Cadila Healthcare Limited, the company operates as a subsidiary of Zydus Family Trust.

Key Fundamentals

EPS44.87
P/E26.16
ROE17.33
RPS284
ROIC11.35
ROA9.70
Interest Cover10.41
EBITDA, mln82,419
EV / EBITDA15.41
EV / EBIT19.49
Revenue, mln285,917
EV / Revenue4.44

Quote Details

Last 1,177.60
Change 10.6 (0.91%)
Open 1,169.95
Volume 6,526
Turnover 7,685,018
Average Volume 70,313

Financial Ratios

Pre-Tax Profit Margin21
Current Ratio1.27
Price / Book3.96
Price / Tangible Book9.62
Price / Cash Flow120
Price / Free Cash Flow1,435
Debt / Equity0.46
Price / Sales4.09
PEG Ratio1.02

Financial Strength

Altman Z-Score4.95
Piotroski F-Score 3 / 9
Beneish M-Score-2.15
Price to Intrinsic Value2.32
Price to Lynch Fair Value0.96
Price to Graham Number3.04
1-Year Target Price1,220.98
Shiller PE Ratio38.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.4% 90 / 100   
1 Month -2.03% 75 / 100   
2 Months 3.11% 74 / 100   
6 Months 26.49% 84 / 100   
1 Year 19.38% 81 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog